| # | Title | Journal | Year | Citations |
|---|
| 1 | Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease | New England Journal of Medicine | 2000 | 1,113 |
| 2 | Relation Between Troponin T and the Risk of Subsequent Cardiac Events in Unstable Coronary Artery Disease | Circulation | 1996 | 490 |
| 3 | Troponin T Identifies Patients With Unstable Coronary Artery Disease Who Benefit From Long-Term Antithrombotic Protection | Journal of the American College of Cardiology | 1997 | 392 |
| 4 | The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes | European Heart Journal | 2017 | 339 |
| 5 | Quantitative Assessment of Myocardial Perfusion in the Detection of Significant Coronary Artery Disease | Journal of the American College of Cardiology | 2014 | 253 |
| 6 | 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS | Europace | 2018 | 243 |
| 7 | Use Of 13 Disease Registries In 5 Countries Demonstrates The Potential To Use Outcome Data To Improve Health Care’s Value | Health Affairs | 2012 | 178 |
| 8 | Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy) | American Journal of Cardiology | 2002 | 151 |
| 9 | Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry | European Heart Journal | 2017 | 151 |
| 10 | Normal Plasma Levels of Cardiac Troponin I Measured by the High-Sensitivity Cardiac Troponin I Access Prototype Assay and the Impact on the Diagnosis of Myocardial Ischemia | Journal of the American College of Cardiology | 2009 | 149 |
| 11 | The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial | European Heart Journal | 2008 | 132 |
| 12 | A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference | Europace | 2016 | 121 |
| 13 | Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies | Europace | 2017 | 120 |
| 14 | Risk stratification in unstable coronary artery disease: Additive value of troponin T determinations and pre-discharge exercise tests | European Heart Journal | 1997 | 108 |
| 15 | CRT Survey II: a European Society of Cardiology survey of cardiac resynchronisation therapy in 11 088 patients—who is doing what to whom and how? | European Journal of Heart Failure | 2018 | 107 |
| 16 | Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial | European Heart Journal | 2015 | 98 |
| 17 | Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference | Europace | 2018 | 95 |
| 18 | Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring | Coronary Artery Disease | 1995 | 68 |
| 19 | Increased fibrinogen levels are associated with persistentChlamydia pneumoniaeinfection in unstable coronary artery disease | European Heart Journal | 1998 | 63 |
| 20 | Eptifibatide Is Noninferior to Abciximab in Primary Percutaneous Coronary Intervention | Journal of the American College of Cardiology | 2010 | 62 |
| 21 | Ablation of atrial fibrillation with cryoballoon or duty-cycled radiofrequency pulmonary vein ablation catheter: a randomized controlled study comparing the clinical outcome and safety; the AF-COR study | Europace | 2013 | 60 |
| 22 | The use of wearable cardioverter-defibrillators in Europe: results of the European Heart Rhythm Association survey | Europace | 2016 | 60 |
| 23 | Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease—indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey | Europace | 2017 | 60 |
| 24 | An update on atrial fibrillation in 2014: From pathophysiology to treatment | International Journal of Cardiology | 2016 | 56 |
| 25 | Assessment of Use vs Discontinuation of Oral Anticoagulation After Pulmonary Vein Isolation in Patients With Atrial Fibrillation | JAMA Cardiology | 2017 | 54 |
| 26 | Prognostic implications of left ventricular myocardial work indices in cardiac amyloidosis | European Heart Journal Cardiovascular Imaging | 2021 | 54 |
| 27 | Early assessment of patients with suspected acute myocardial infarction by biochemical monitoring and neural network analysis | Clinical Chemistry | 1997 | 52 |
| 28 | Patients’ attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association | Europace | 2016 | 50 |
| 29 | Left Ventricular Pressure-Strain–Derived Myocardial Work at Rest and during Exercise in Patients with Cardiac Amyloidosis | Journal of the American Society of Echocardiography | 2020 | 50 |
| 30 | Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association | Europace | 2016 | 49 |
| 31 | Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy | Heart | 2014 | 47 |
| 32 | Current ablation techniques for persistent atrial fibrillation: results of the European Heart Rhythm Association Survey | Europace | 2015 | 46 |
| 33 | The use of imaging for electrophysiological and devices procedures: a report from the first European Heart Rhythm Association Policy Conference, jointly organized with the European Association of Cardiovascular Imaging (EACVI), the Council of Cardiovascular Imaging and the European Society of Cardiac Radiology | Europace | 2013 | 38 |
| 34 | Catheter ablation for atrial fibrillation: results from the first European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA) Part II | Europace | 2015 | 36 |
| 35 | Patients’ knowledge and attitudes regarding living with implantable electronic devices: results of a multicentre, multinational patient survey conducted by the European Heart Rhythm Association | Europace | 2018 | 35 |
| 36 | Noninvasive Risk Stratification in Unstable Coronary Artery Disease | American Journal of Cardiology | 1997 | 32 |
| 37 | Management of malfunctioning and recalled pacemaker and defibrillator leads: results of the European Heart Rhythm Association survey | Europace | 2014 | 32 |
| 38 | Use of fluoroscopy in clinical electrophysiology in Europe: results of the European Heart Rhythm Association Survey | Europace | 2015 | 32 |
| 39 | Clinical management of arrhythmias in elderly patients: results of the European Heart Rhythm Association survey | Europace | 2015 | 30 |
| 40 | Use of event recorders and loop recorders in clinical practice: results of the European Heart Rhythm Association Survey | Europace | 2014 | 28 |
| 41 | Long-Term Low-Molecular-Weight Heparin (Fragmin) and/or Early Revascularization During Instability in Coronary Artery Disease (the FRISC II Study) | American Journal of Cardiology | 1997 | 27 |
| 42 | How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey | Europace | 2015 | 27 |
| 43 | Comparison of effects on coagulation and inflammatory markers using a duty-cycled bipolar and unipolar radiofrequency pulmonary vein ablation catheter vs. a cryoballoon catheter for pulmonary vein isolation | Europace | 2013 | 26 |
| 44 | Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey | Europace | 2013 | 24 |
| 45 | How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey | Europace | 2014 | 24 |
| 46 | The changing circumstance of atrial fibrillation ‐ progress towards precision medicine | Journal of Internal Medicine | 2016 | 24 |
| 47 | Understanding the use of observational and randomized data in cardiovascular medicine | European Heart Journal | 2020 | 24 |
| 48 | Risk stratification in unstable coronary artery disease | Journal of the American College of Cardiology | 2000 | 23 |
| 49 | Performing magnetic resonance imaging in patients with implantable pacemakers and defibrillators: results of a European Heart Rhythm Association survey | Europace | 2012 | 23 |
| 50 | ELECTRa (European Lead Extraction ConTRolled) Registry—Shedding light on transvenous lead extraction real-world practice in Europe | Herzschrittmachertherapie Und Elektrophysiologie | 2013 | 23 |
